Cargando…
A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes
AIM: To construct a simple screening tool for predicting diabetic kidney disease in Chinese patients with type 2 diabetes. MATERIALS AND METHODS: In the development cohort, the clinical and procedural characteristics of the 4,795 patients were considered as candidate univariate predictors of diabeti...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731980/ https://www.ncbi.nlm.nih.gov/pubmed/29254270 http://dx.doi.org/10.18632/oncotarget.21684 |
_version_ | 1783286605235093504 |
---|---|
author | Wu, Mian Lu, Junxi Zhang, Lei Liu, Fengjing Chen, Si Han, Ying Zhao, Fangya Guo, Kaifeng Bao, Yuqian Chen, Haibing Jia, Weiping |
author_facet | Wu, Mian Lu, Junxi Zhang, Lei Liu, Fengjing Chen, Si Han, Ying Zhao, Fangya Guo, Kaifeng Bao, Yuqian Chen, Haibing Jia, Weiping |
author_sort | Wu, Mian |
collection | PubMed |
description | AIM: To construct a simple screening tool for predicting diabetic kidney disease in Chinese patients with type 2 diabetes. MATERIALS AND METHODS: In the development cohort, the clinical and procedural characteristics of the 4,795 patients were considered as candidate univariate predictors of diabetic kidney disease. The β-coefficients derived from a multiple logistic regression model predicting the presence of DKD were used to calculate the risk score. The performance of the risk score was validated in a cross-sectional and a prospective cohort population. RESULTS: The risk score included sex, body mass index, systolic blood pressure, and duration of diabetes. The total point ranged from 0 to 39. In the development cohort, compared with participants with risk score < 10, those with risk score between 10 to 20, 21 to 30, and > 30 had ORs of 3.21, 7.92 and 17.55 for developing diabetic kidney disease, respectively. In the prospective cohort, 60.9% patients with risk score over 30 were expected to develop DKD at 72 months of follow-up. CONCLUSIONS: Sex, body mass index, systolic blood pressure, and duration of diabetes were independent predictors of diabetic kidney disease, and the derived risk equation was a simple screening tool for screening diabetic kidney disease in Chinese patients with type 2 diabetes. |
format | Online Article Text |
id | pubmed-5731980 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-57319802017-12-17 A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes Wu, Mian Lu, Junxi Zhang, Lei Liu, Fengjing Chen, Si Han, Ying Zhao, Fangya Guo, Kaifeng Bao, Yuqian Chen, Haibing Jia, Weiping Oncotarget Clinical Research Paper AIM: To construct a simple screening tool for predicting diabetic kidney disease in Chinese patients with type 2 diabetes. MATERIALS AND METHODS: In the development cohort, the clinical and procedural characteristics of the 4,795 patients were considered as candidate univariate predictors of diabetic kidney disease. The β-coefficients derived from a multiple logistic regression model predicting the presence of DKD were used to calculate the risk score. The performance of the risk score was validated in a cross-sectional and a prospective cohort population. RESULTS: The risk score included sex, body mass index, systolic blood pressure, and duration of diabetes. The total point ranged from 0 to 39. In the development cohort, compared with participants with risk score < 10, those with risk score between 10 to 20, 21 to 30, and > 30 had ORs of 3.21, 7.92 and 17.55 for developing diabetic kidney disease, respectively. In the prospective cohort, 60.9% patients with risk score over 30 were expected to develop DKD at 72 months of follow-up. CONCLUSIONS: Sex, body mass index, systolic blood pressure, and duration of diabetes were independent predictors of diabetic kidney disease, and the derived risk equation was a simple screening tool for screening diabetic kidney disease in Chinese patients with type 2 diabetes. Impact Journals LLC 2017-10-09 /pmc/articles/PMC5731980/ /pubmed/29254270 http://dx.doi.org/10.18632/oncotarget.21684 Text en Copyright: © 2017 Wu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Clinical Research Paper Wu, Mian Lu, Junxi Zhang, Lei Liu, Fengjing Chen, Si Han, Ying Zhao, Fangya Guo, Kaifeng Bao, Yuqian Chen, Haibing Jia, Weiping A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes |
title | A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes |
title_full | A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes |
title_fullStr | A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes |
title_full_unstemmed | A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes |
title_short | A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes |
title_sort | non-laboratory-based risk score for predicting diabetic kidney disease in chinese patients with type 2 diabetes |
topic | Clinical Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731980/ https://www.ncbi.nlm.nih.gov/pubmed/29254270 http://dx.doi.org/10.18632/oncotarget.21684 |
work_keys_str_mv | AT wumian anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT lujunxi anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT zhanglei anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT liufengjing anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT chensi anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT hanying anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT zhaofangya anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT guokaifeng anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT baoyuqian anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT chenhaibing anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT jiaweiping anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT wumian nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT lujunxi nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT zhanglei nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT liufengjing nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT chensi nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT hanying nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT zhaofangya nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT guokaifeng nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT baoyuqian nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT chenhaibing nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes AT jiaweiping nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes |